http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005306798-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ef4e459dae0beb9149db1eec84d20ee |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-08 |
| filingDate | 2004-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd4fe80ff519faa07d23fd8589bb5764 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd8537d60ed7f9efcc656eb5398a35ec |
| publicationDate | 2005-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2005306798-A |
| titleOfInvention | Cyclophosphamide treatment for improving side effects |
| abstract | PROBLEM TO BE SOLVED: To provide an alkylating agent such as cyclophosphamide, which has an action of damaging a gene of a cell in a growth phase and acts not only on a cancer cell but also on a normal cell to cause side effects, particularly leucopenia. . Accordingly, it is an object of the present invention to provide a treatment method for improving leukopenia without causing patient pain. SOLUTION: Oral administration of mineral water, particularly selective desalted water obtained by desalting deep sea water by electrodialysis, to a patient improves the mineral balance in the patient's human body, thereby reducing side effects caused by taking cyclophosphamide. Can improve certain leukopenia. [Selection] Figure 1 |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101841042-B1 |
| priorityDate | 2004-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.